Title : Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6 - Brioschi_2021_Alzheimers.Res.Ther_13_172 |
Author(s) : Brioschi Guevara A , Bieler M , Altomare D , Berthier M , Csajka C , Dautricourt S , Demonet JF , Dodich A , Frisoni GB , Miniussi C , Molinuevo JL , Ribaldi F , Scheltens P , Chetelat G |
Ref : Alzheimers Res Ther , 13 :172 , 2021 |
Abstract : |
PubMedSearch : Brioschi_2021_Alzheimers.Res.Ther_13_172 |
PubMedID: 34635149 |
Title : Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid - Lleo_2019_Mol.Cell.Proteomics_18_546 |
Author(s) : Lleo A , Nunez-Llaves R , Alcolea D , Chiva C , Balateu-Panos D , Colom-Cadena M , Gomez-Giro G , Munoz L , Querol-Vilaseca M , Pegueroles J , Rami L , Llado A , Molinuevo JL , Tainta M , Clarimon J , Spires-Jones T , Blesa R , Fortea J , Martinez-Lage P , Sanchez-Valle R , Sabido E , Bayes A , Belbin O |
Ref : Mol Cell Proteomics , 18 :546 , 2019 |
Abstract : |
PubMedSearch : Lleo_2019_Mol.Cell.Proteomics_18_546 |
PubMedID: 30606734 |
Title : Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials - Atri_2018_JAMA_319_130 |
Author(s) : Atri A , Frolich L , Ballard C , Tariot PN , Molinuevo JL , Boneva N , Windfeld K , Raket LL , Cummings JL |
Ref : Jama , 319 :130 , 2018 |
Abstract : |
PubMedSearch : Atri_2018_JAMA_319_130 |
PubMedID: 29318278 |
Title : Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program - Cummings_2018_Alzheimers.Res.Ther_10_116 |
Author(s) : Cummings JL , Atri A , Ballard C , Boneva N , Frolich L , Molinuevo JL , Raket LL , Tariot PN |
Ref : Alzheimers Res Ther , 10 :116 , 2018 |
Abstract : |
PubMedSearch : Cummings_2018_Alzheimers.Res.Ther_10_116 |
PubMedID: 30474567 |
Title : EFNS-ENS\/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease - Schmidt_2015_Eur.J.Neurol_22_889 |
Author(s) : Schmidt R , Hofer E , Bouwman FH , Buerger K , Cordonnier C , Fladby T , Galimberti D , Georges J , Heneka MT , Hort J , Laczo J , Molinuevo JL , O'Brien JT , Religa D , Scheltens P , Schott JM , Sorbi S |
Ref : Eur Journal of Neurology , 22 :889 , 2015 |
Abstract : |
PubMedSearch : Schmidt_2015_Eur.J.Neurol_22_889 |
PubMedID: 25808982 |
Title : Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis - Atri_2015_Alzheimers.Res.Ther_7_28 |
Author(s) : Atri A , Hendrix SB , Pejovic V , Hofbauer RK , Edwards J , Molinuevo JL , Graham SM |
Ref : Alzheimers Res Ther , 7 :28 , 2015 |
Abstract : |
PubMedSearch : Atri_2015_Alzheimers.Res.Ther_7_28 |
PubMedID: 25991927 |
Title : Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease - Gauthier_2013_Alzheimers.Dement_9_326 |
Author(s) : Gauthier S , Molinuevo JL |
Ref : Alzheimers Dement , 9 :326 , 2013 |
Abstract : |
PubMedSearch : Gauthier_2013_Alzheimers.Dement_9_326 |
PubMedID: 23110864 |
Title : Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy - Atri_2013_Alzheimers.Res.Ther_5_6 |
Author(s) : Atri A , Molinuevo JL , Lemming O , Wirth Y , Pulte I , Wilkinson D |
Ref : Alzheimers Res Ther , 5 :6 , 2013 |
Abstract : |
PubMedSearch : Atri_2013_Alzheimers.Res.Ther_5_6 |
PubMedID: 23336974 |
Title : [Memantine: the value of combined therapy] - Molinuevo_2011_Rev.Neurol_52_95 |
Author(s) : Molinuevo JL |
Ref : Rev Neurol , 52 :95 , 2011 |
Abstract : |
PubMedSearch : Molinuevo_2011_Rev.Neurol_52_95 |
PubMedID: 21271549 |